Activation of KCa3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of KCa3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 170, Issue 2, Pages 293-303
Publisher
Wiley
Online
2013-06-04
DOI
10.1111/bph.12267
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- KCa3.1 channels maintain endothelium-dependent vasodilatation in isolated perfused kidneys of spontaneously hypertensive rats after chronic inhibition of NOS
- (2012) Serge Simonet et al. BRITISH JOURNAL OF PHARMACOLOGY
- Defective Cx40 Maintains Cx37 Expression but Intact Cx40 Is Crucial for Conducted Dilations Irrespective of Hypertension
- (2012) Alexander Jobs et al. HYPERTENSION
- Genetic KCa3.1-Deficiency Produces Locomotor Hyperactivity and Alterations in Cerebral Monoamine Levels
- (2012) Kate Lykke Lambertsen et al. PLoS One
- Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs
- (2011) Mads Damkjaer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Distinct Endothelium-Derived Hyperpolarizing Factors Emerge In Vitro and In Vivo and Are Mediated in Part via Connexin 40–Dependent Myoendothelial Coupling
- (2011) Markus Boettcher et al. HYPERTENSION
- Opening of Small and Intermediate Calcium-Activated Potassium Channels Induces Relaxation Mainly Mediated by Nitric-Oxide Release in Large Arteries and Endothelium-Derived Hyperpolarizing Factor in Small Arteries from Rat
- (2011) E. Stankevicius et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Amplification of EDHF-type vasodilatations in TRPC1-deficient mice
- (2010) Kjestine Schmidt et al. BRITISH JOURNAL OF PHARMACOLOGY
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- EDHF: spreading the influence of the endothelium
- (2010) Christopher J Garland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cardiac Small Conductance Ca 2+ -Activated K + Channel Subunits Form Heteromultimers via the Coiled-Coil Domains in the C Termini of the Channels
- (2010) Dipika Tuteja et al. CIRCULATION RESEARCH
- Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease
- (2010) Ralf Köhler et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Crucial importance of the endothelial K+ channel SK3 and connexin40 in arteriolar dilations during skeletal muscle contraction
- (2010) Malte Milkau et al. FASEB JOURNAL
- Selective deletion of Connexin 40 in renin-producing cells impairs renal baroreceptor function and is associated with arterial hypertension
- (2010) Charlotte Wagner et al. KIDNEY INTERNATIONAL
- Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses
- (2010) Cor de Wit et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Endothelium-derived hyperpolarising factors and associated pathways: a synopsis
- (2010) Gillian Edwards et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Endothelial Ca2+-activated K+ channels in normal and impaired EDHF-dilator responses - relevance to cardiovascular pathologies and drug discovery
- (2009) Ivica Grgic et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo
- (2009) Stephanie E. Wölfle et al. CARDIOVASCULAR RESEARCH
- Different pathways with distinct properties conduct dilations in the microcirculation in vivo
- (2009) Cor de Wit CARDIOVASCULAR RESEARCH
- Genetic Deficit of SK3 and IK1 Channels Disrupts the Endothelium-Derived Hyperpolarizing Factor Vasodilator Pathway and Causes Hypertension
- (2009) Sebastian Brähler et al. CIRCULATION
- Endothelial-Specific Deletion of Connexin40 Promotes Atherosclerosis by Increasing CD73-Dependent Leukocyte Adhesion
- (2009) C.E. Chadjichristos et al. CIRCULATION
- EDHF: an update
- (2009) Michel Félétou et al. CLINICAL SCIENCE
- Endothelium-dependent Vasodilation in Myogenically Active Mouse Skeletal Muscle Arterioles: Role of EDH and K+Channels
- (2009) Simon J. Potocnik et al. MICROCIRCULATION
- The Myoendothelial Junction: Breaking through the Matrix?
- (2009) Katherine R. Heberlein et al. MICROCIRCULATION
- Incidence of protein on actin bridges between endothelium and smooth muscle in arterioles demonstrates heterogeneous connexin expression and phosphorylation
- (2008) Brant E. Isakson et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar vasodilation
- (2008) Jian-zhong Sheng et al. FASEB JOURNAL
- Substitution of connexin40 with connexin45 prevents hyperreninemia and attenuates hypertension
- (2008) Frank Schweda et al. KIDNEY INTERNATIONAL
- Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a New Activator of KCa2 and KCa3.1 Potassium Channels, Potentiates the Endothelium-Derived Hyperpolarizing Factor Response and Lowers Blood Pressure
- (2008) A. Sankaranarayanan et al. MOLECULAR PHARMACOLOGY
- Functional Roles of a Ca 2+ -Activated K + Channel in Atrioventricular Nodes
- (2007) Qian Zhang et al. CIRCULATION RESEARCH
- Connexin-mimetic peptides dissociate electrotonic EDHF-type signalling via myoendothelial and smooth muscle gap junctions in the rabbit iliac artery
- (2004) Andrew T Chaytor et al. BRITISH JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started